GALNT6 (polypeptide N-acetylgalactosaminyltransferase 6)

symbol:
GALNT6
locus group:
protein-coding gene
location:
12q13.13
gene_family:
Polypeptide N-acetylgalactosaminyltransferases
alias symbol:
GalNAc-T6
alias name:
polypeptide GalNAc transferase 6
entrez id:
11226
ensembl gene id:
ENSG00000139629
ucsc gene id:
uc001ryl.2
refseq accession:
NM_007210
hgnc_id:
HGNC:4128
approved reserved:
1999-09-16
12q13.13

GALNT6(多肽N-乙酰氨基半乳糖转移酶6)属于GALNT基因家族,该家族由20个成员组成,负责催化蛋白质O-糖基化的第一步反应,即在丝氨酸或苏氨酸残基上添加N-乙酰氨基半乳糖(GalNAc)。这种翻译后修饰对蛋白质功能、稳定性和细胞间通讯至关重要。GALNT6在多种组织中表达,尤其在乳腺、卵巢和胰腺中活性较高。其表达产物通过糖基化修饰影响粘蛋白型O-糖链的形成,参与细胞粘附、信号转导和免疫应答等过程。该基因的突变可能导致糖基化异常,与多种疾病相关,特别是癌症。研究发现GALNT6在乳腺癌、卵巢癌和胰腺癌中经常过表达,其过表达会增强EGFR等受体的糖基化,促进肿瘤细胞增殖、迁移和侵袭。相反,降低GALNT6表达可抑制这些恶性行为。GALNT6还通过调节MUC1等粘蛋白的糖基化影响肿瘤微环境。此外,GALNT6异常表达与阿尔茨海默病等神经退行性疾病也有关联,可能通过影响tau蛋白的糖基化参与病理过程。GALNT基因家族的共性在于都含有保守的糖基转移酶结构域,但各成员具有组织特异性表达模式和底物偏好性,这种多样性使它们能精细调控不同蛋白质的O-糖基化。GALNT6作为该家族重要成员,其表达水平变化会显著影响细胞表面受体和分泌蛋白的糖基化状态,进而改变细胞行为。

ChineseEnglish

This gene encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. The encoded protein is capable of glycosylating fibronectin peptide in vitro and is expressed in a fibroblast cell line, indicating that it may be involved in the synthesis of oncofetal fibronectin. [provided by RefSeq, Jul 2008]

Nucleotide sequence of GALNT6:[NCBI]
Loading Gene Browser...
Protein Sequence
1MRLLRRRHMP LRLAMVGCAF VLFLFLLHRD VSSREEATEK
41PWLKSLVSRK DHVLDLMLEA MNNLRDSMPK LQIRAPEAQQ
81 TLFSINQSC LPGFYTPAEL KPFWERPPQD PNAPGADGKA
121FQKSKWTPLE TQEKEEGYKK HCFNAFASDR ISLQRSLGPD
161T RPPECVDQ KFRRCPPLAT TSVIIVFHNE AWSTLLRTVY
201SVLHTTPAIL LKEIILVDDA STEEHLKEKL EQYVKQLQVV
241RV VRQEERK GLITARLLGA SVAQAEVLTF LDAHCECFHG
281WLEPLLARIA EDKTVVVSPD IVTIDLNTFE FAKPVQRGRV
321HSR GNFDWS LTFGWETLPP HEKQRRKDET YPIKSPTFAG
361GLFSISKSYF EHIGTYDNQM EIWGGENVEM SFRVWQCGGQ
401LEII PCSVV GHVFRTKSPH TFPKGTSVIA RNQVRLAEVW
441MDSYKKIFYR RNLQAAKMAQ EKSFGDISER LQLREQLHCH
481NFSWY LHNV YPEMFVPDLT PTFYGAIKNL GTNQCLDVGE
521NNRGGKPLIM YSCHGLGGNQ YFEYTTQRDL RHNIAKQLCL
561HVSKGA LGL GSCHFTGKNS QVPKDEEWEL AQDQLIRNSG
601SGTCLTSQDK KPAMAPCNPS DPHQLWLFV
结构预测来自 AlphaFold DB(UniProt: Q8NCL4),颜色表示 pLDDT 置信度(深蓝高、黄橙低)。
SNP variants of GALNT6:           Showing partial SNPs
rs2519       rs10516       rs11341       rs747300       rs747301       rs749979       rs907347       rs907352       rs1991432       rs2042866       rs2067763       rs2067764       rs2114875       rs2241545       rs2277379       rs2277380       rs2278216      

Tissue expression of GALNT6:    [UniProt]

Gene expression across tissues
Forward Primer
Forward Tm
Reverse Primer
Reverse Tm
Score
CAGTTGTTCAGATTCCCAGG
59
TGCAATGGTTCAGAATCACC
59
GAGATTCAATGCCCAAGCTC
59
ATGGAGAACAGAGTCTGCT
58
TGAGTGAATCAGTCAGGAGG
59
AAGAGGAAGAGCACAAAGG
57
GAACAGTGTACAGCGTCCT
60
TTTAGGTGCTCCTCTGTGC
60
GATGTGGGTGAGAACAACC
59
CTCAAAGTACTGGTTGCCG
59
AGTGAATCAGTCAGGAGGC
59
AGCTTGATACGTTGTGGTG
58
GATGTGGGTGAGAACAACC
59
CTCAAAGTACTGGTTGCCG
59
TTGATTCTGCTTCTCACAGG
58
TAGCTTGATACGTTGTGGTG
58
TGAGTGAATCAGTCAGGAGG
59
AAGAGGAAGAGCACAAAGG
57
TGAGTGAATCAGTCAGGAGG
59
AAGAGGAAGAGCACAAAGG
57
      No data available

Subcellular localization of GALNT6 (and its protein):

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • plasma membrane
  • cytoplasm
  • extracellular
  • golgi
  • vesicle
  • cytoskeleton
  • endoplasmic reticulum
  • nucleus
  • endosome
  • lysosome
  • mitochondrion

Gene Ontology (GO) terms for GALNT6:

GO ID
Protein
Source DB
GO:0000139
Q8NCL4 (UniProtKB)
TAS
GO:0004653
Q8NCL4 (UniProtKB)
TAS
GO:0005794
Q8NCL4 (UniProtKB)
IDA
GO:0006493
Q8NCL4 (UniProtKB)
TAS
GO:0016021
Q8NCL4 (UniProtKB)
IEA
GO:0016266
Q8NCL4 (UniProtKB)
TAS
GO:0030246
Q8NCL4 (UniProtKB)
IEA
GO:0046872
Q8NCL4 (UniProtKB)
IEA
GO:0048471
Q8NCL4 (UniProtKB)
IDA

microRNAs potentially regulating GALNT6:     

String
BioGrid
IntAct
mentha
Reactome
Loading…
Interacting Gene Interaction Source/Score
Disease Score NofPmids NofSnps Source
Disease Score NofPmids NofSnps Source
Tobacco Use Disorder 0.002367032 1 0 GAD
Breast Carcinoma 0.000814326 3 0 BeFree
Malignant neoplasm of breast 0.000814326 3 0 BeFree
Mammary Neoplasms 0.000271442 1 0 BeFree
Carcinogenesis 0.000271442 1 0 BeFree
First exploratory GWAS of parasite resistance in Pelibuey sheep identifying biologically plausible candidate loci.
Esparza-Acebo LM, Ojeda-Robertos NF, De La Rosa-Reyna XF, Parra-Bracamonte GM Vet Parasitol Reg Stud Reports IF: 1.6 2026-08-00
Genome-wide association study of myopia progression in Chinese adolescents and application of polygenic risk score prediction.
Liu Q, Shen H, Dang X, He MZ, Wei Y, Shi Y, Wei X, Chen F, Han D, Liu C, Hu J, Liu W Front Chem IF: 5.3 None
Aberrant O-glycosylation genes and miR-21-5p targets define a molecular signature of tumor aggressiveness in triple-negative breast cancer.
Murillo Carrasco AG, Landeira M, Furuya TK, Ferreira Alves MJ, Lobo Kolarik M, Machado Colli L, Pintor Dos Reis P, Chammas R, Freire T Glycobiology IF: 3.3 2026-05-22
GALNT6-mediated O-glycosylation on PTGS2 regulates microglia inflammation and ferroptosis following intracerebral hemorrhage.
Han C, Hou X, Zhang F, Wang P, Xia X, Xiao H, Jiao S, Cao F, Yao S Int Immunopharmacol IF: 5.6 2026-10-01
The ocular surface consequences of lacrimal gland loss are life-stage dependent.
Han J, Liu R, Qiu C, Qian X, Xue J, Chen Z, Liang L Ocul Surf IF: 6.6 2026-06-26
GALNT6 localization is associated with gland-forming architecture and morphological differentiation in luminal A breast cancer.
Takahashi K, Uzuki M, Matsuda R, Yazawa Y, Kawata K, Shimoyama N, Munakata S, Hashimoto Y, Ohtake T, Kitazume S Biochim Biophys Acta Gen Subj IF: 2.9 2026-10-00

Loading comments...

Log in to post comments Log In Sign Up

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com